Copia Wealth Management Abb Vie Inc. Transaction History
Copia Wealth Management
- $135 Billion
- Q3 2025
A detailed history of Copia Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Copia Wealth Management holds 368 shares of ABBV stock, worth $80,485. This represents 0.06% of its overall portfolio holdings.
Number of Shares
368
Previous 108
240.74%
Holding current value
$80,485
Previous $20 Million
325.04%
% of portfolio
0.06%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
4,439Shares Held
1.3BCall Options Held
15.6MPut Options Held
11.1M-
Vanguard Group Inc Valley Forge, PA178MShares$38.9 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$29.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$17.5 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$12.4 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.12 Billion0.52% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $387B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...